Table 1.
Baseline characteristics of all IgAN patients.
| Total (N = 98) | |
|---|---|
| Age (years) | 45.11 ± 13.60 |
| Male (%) | 46 (46.9%) |
| Diabetes (%) | 7 (7.1%) |
| Hypertension (%) | 43 (43.8) |
| Use of ACEI/ARB (%) | 63 (63.3%) |
| UPCR (g/g) | 2.78 ± 3.14 |
| Creatinine (mg/dL) | 1.68 ± 1.29 |
| eGFR (ml/min/1.73m2) | 55.22 ± 34.13 |
| Gd-IgA1 Ab titer (ng/mL) | 7920 (5129-11708) |
| C5a (ng/mL) | 3476 (1095-4913) |
| Factor Ba (ng/mL) | 2865 (1425-4379) |
Normally-distributed continuous variables including age, UPCR, creatine, eGFR are expressed as mean ± standard deviation. Non-normally-distributed continuous variables such as Gd-IgA1 Ab titer, C5a and Factor Ba level are expressed as median (interquartile range).